Publications by authors named "Hideaki Maeda"

Claim this Profile
R
Recommendations for the management of the vascular involvement in Behçet's disease by the Japanese National Research Committee for Behçet's disease-secondary publication.
Hiroko Nagafuchi, Hirotoshi Kikuchi, Hiroyuki Ishibash, Hideaki Maeda, Hitoshi Ogino

Mod Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostication of Patients with Pulmonary Thromboembolism with and without Residual Deep Vein Thrombosis: A Subanalysis of the J'xactly Study.
Norikazu Yamada, Ikuo Fukuda, Mashio Nakamura, Morimasa Takayama, Hideaki Maeda

Ann Vasc Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Profile and Effectiveness of Rivaroxaban for Patients With Venous Thromboembolism in Japan　- Results From Post-Marketing Surveillance (XASSENT).
Ikuo Fukuda, Atsushi Hirayama, Kazuo Kawasugi, Takao Kobayashi, Hideaki Maeda

Circ J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J'xactly study.
Shohei Migita, Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Hideaki Maeda

Thromb J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Prediction models for two-year overall survival and amputation free survival after revascularization for chronic limb threatening ischemia. [Volume 64, Issue 4, October 2022, Pages 367-76]".
Tetsuro Miyata, Hiraku Kumamaru, Shinsuke Mii, Naoko Kinukawa, Hiroaki Miyata, Maeda Hideaki

Eur J Vasc Endovasc Surg· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism　- Subanalysis of the J'xactly Study.
Mashio Nakamura, Ikuo Fukuda, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda

Circ Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of rivaroxaban in patients with venous thromboembolism and active cancer: A subanalysis of the J'xactly study.
Shinji Hisatake, Takanori Ikeda, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Hideaki Maeda

J Cardiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of the direct oral anticoagulant in acute distal deep vein thrombosis: From the prospective multicenter observational study, J'xactly, in Japan.
Makoto Mo, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda

Phlebology· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between baseline D-dimer and prognosis in Japanese patients with venous thromboembolism: Insights from the J'xactly study.
Shohei Migita, Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Hideaki Maeda

Front Cardiovasc Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction Models for Two Year Overall Survival and Amputation Free Survival After Revascularisation for Chronic Limb Threatening Ischaemia.
Tetsuro Miyata, Hiraku Kumamaru, Shinsuke Mii, Naoko Kinukawa, Hiroaki Miyata, Maeda Hideaki

Eur J Vasc Endovasc Surg· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism　- Subanalysis of the J'xactly Study.
Shinji Hisatake, Takanori Ikeda, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Hideaki Maeda

Circ Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism　- Insights From the J'xactly Study.
Takeshi Yamashita, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda

Circ Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and clinical outcomes of Japanese patients with venous thromboembolism receiving under-dose rivaroxaban: subanalysis of J'xactly.
Daisuke Fukamachi, Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Hideaki Maeda

Curr Med Res Opin· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implication of the Right Ventricular/Left Ventricular Diameter Ratio in Patients with Pulmonary Thromboembolism.
Masatsugu Miyagawa, Yasuo Okumura, Daisuke Fukamachi, Ikuo Fukuda, Mashio Nakamura, Hideaki Maeda

Int Heart J· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT).
Ikuo Fukuda, Atsushi Hirayama, Kazuo Kawasugi, Takao Kobayashi, Hideaki Maeda

TH Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CORRIGENDUM: A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J'xactly Study).
Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda

Circ J· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J'xactly Study).
Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda

Circ J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of ultrasound imaging in operative treatment for a rare case of inferior vena cava tumor.
Ayako Iida, Hideaki Maeda, Yusuke Ishii, Michinari Kono, Atsushi Harada

J Med Ultrason (2001)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Structural Analysis of the Terminal Groups in Commercial Natural Rubber by 2D-NMR with DOSY Filters and Multiple-WET Methods Using Ultrahigh-Field NMR".
Muneki Oouchi, Jinta Ukawa, Yoshitaka Ishii, Hideaki Maeda

Biomacromolecules· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future prospects for NMR magnets: A perspective.
Hideaki Maeda, Yoshinori Yanagisawa

J Magn Reson· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Incidence of Cancer in Japanese Patients with Critical Limb Ischemia.
Atsushi Akai, Hiroshi Shigematsu, Tetsuro Miyata, Hideaki Maeda, Toshihiro Onohara

Ann Vasc Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Analysis of the Terminal Groups in Commercial Hevea Natural Rubber by 2D-NMR with DOSY Filters and Multiple-WET Methods Using Ultrahigh-Field NMR.
Muneki Oouchi, Jinta Ukawa, Yoshitaka Ishii, Hideaki Maeda

Biomacromolecules· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study.
Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda

BMJ Open· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
24 T High-Resolution and -Sensitivity Solid-State NMR Measurements of Low-Gamma Half-Integer Quadrupolar Nuclei Cl and Cl.
Manoj Kumar Pandey, Kenjiro Hashi, Shinobu Ohki, Gen Nishijima, Shinji Matsumoto, Hideaki Maeda

Anal Sci· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Houttuynoid M, an Anti-HSV Active Houttuynoid from Houttuynia cordata Featuring a Bis-houttuynin Chain Tethered to a Flavonoid Core.
Jiao-Jiao Li, Guo-Dong Chen, Hong-Xia Fan, Dan Hu, Zheng-Qun Zhou, Hideaki Maeda

J Nat Prod· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis